The west nile virus-like flavivirus koutango is highly virulent in mice due to delayed viral clearance and the induction of a poor neutralizing antibody response

Journal of Virology

Volumn 88, Issue 17, 2014, Pages 9947-9962

  Prow, Natalie A ^a   Setoh, Yin X ^a   Biron, Rebecca M ^a   Sester, David P ^a   Kim, Kwang Sik ^b   Hobson Peters, Jody ^a   Hall, Roy A ^a   Bielefeldt Ohmann, Helle ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL; BLOOD; BRAIN; COMPARATIVE STUDY; DISEASE MODEL; EPIDEMIC ENCEPHALITIS; FLAVIVIRUS INFECTION; IMMUNOLOGY; JAPANESE ENCEPHALITIS VIRUS; MOUSE; PATHOGENICITY; PATHOLOGY; SPINAL CORD; SURVIVAL; VIROLOGY; VIRULENCE; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BRAIN; DISEASE MODELS, ANIMAL; ENCEPHALITIS VIRUSES, JAPANESE; ENCEPHALITIS, ARBOVIRUS; FLAVIVIRUS INFECTIONS; MICE; SPINAL CORD; SURVIVAL ANALYSIS; VIRULENCE; VIRUS REPLICATION;

EID: 84921960452     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01304-14     Document Type: Article

References (67)

1. Murgue B, Zeller H, Deubel V. 2002. The ecology and epidemiology of West Nile virus in Africa, Europe and Asia. Curr. Top. Microbiol. Immunol. 267:195-221.
2. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, Steele K, Crise B, Volpe KE, Crabtree MB, Scherret JH, Hall RA, MacKenzie JS, Cropp CB, Panigrahy B, Ostlund E, Schmitt B, Malkinson M, Banet C, Weissman J, Komar N, Savage HM, Stone W, McNamara T, Gubler DJ. 1999. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286:2333-2337. http://dx.doi.org/10.1126/science.286.5448.2333.
3. Murray KO, Mertens E, Despres P. 2010. West Nile virus and its emergence in the United States of America. Vet. Res. 41:67. http://dx.doi.org/10.1051/vetres/2010039.
4. Frost MJ, Zhang J, Edmonds JH, Prow NA, Gu X, Davis R, Hornitzky C, Arzey KE, Finlaison D, Hick P, Read A, Hobson-Peters J, May FJ, Doggett SL, Haniotis J, Russell RC, Hall RA, Khromykh AA, Kirkland PD. 2012. Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg. Infect. Dis. 18:792-800. http://dx.doi.org/10.3201/eid1805.111720.
5. Roche SE, Wicks R, Garner MG, East IJ, Paskin R, Moloney BJ, Carr M, Kirkland P. 2013. Descriptive overview of the 2011 epidemic of arboviral disease in horses in Australia. Aust. Vet. J. 91:5-13. http://dx.doi.org/10.1111/avj.12018.
6. Kutasi O, Bakonyi T, Lecollinet S, Biksi I, Ferenczi E, Bahuon C, Sardi S, Zientara S, Szenci O. 2011. Equine encephalomyelitis outbreak caused by a genetic lineage 2 West Nile virus in Hungary. J. Vet. Intern. Med. 25:586-591. http://dx.doi.org/10.1111/j.1939-1676.2011.0715.x.
7. Mann RA, Fegan M, O'Riley K, Motha J, Warner S. 2013. Molecular characterization and phylogenetic analysis of Murray Valley encephalitis virus and West Nile virus (Kunjin subtype) from an arbovirus disease outbreak in horses in Victoria, Australia, in 2011. J. Vet. Diagn. Investig. 25:35-44. http://dx.doi.org/10.1177/1040638712467985.
8. Spissu N, Panichi G, Montisci A, Fiore F. 2013. West Nile virus outbreak in Sardinia, Italy, in 2011. J. Infect. Dev. Ctries. 7:6-9. http://dx.doi.org/10.3855/jidc.3305.
9. Garcia-Bocanegra I, Jaen-Tellez JA, Napp S, Arenas-Montes A, Fernandez-Morente M, Fernandez-Molera V, Arenas A. 2011. West Nile fever outbreak in horses and humans, Spain, 2010. Emerg. Infect. Dis. 17:2397-2399. http://dx.doi.org/10.3201/eid1712.110651.
10. Danis K, Papa A, Theocharopoulos G, Dougas G, Athanasiou M, Detsis M, Baka A, Lytras T, Mellou K, Bonovas S, Panagiotopoulos T. 2011. Outbreak of West Nile virus infection in Greece, 2010. Emerg. Infect. Dis. 17:1868-1872. http://dx.doi.org/10.3201/eid1710.110525.
11. Arnold C. 2012. West Nile virus bites back. Lancet Neurol. 11:1023-1024. http://dx.doi.org/10.1016/S1474-4422(12)70278-8.
12. Mackenzie JS, Williams DT. 2009. The zoonotic flaviviruses of southern, south-eastern and eastern Asia, and Australasia: the potential for emergent viruses. Zoonoses Public Health 56:338-356. http://dx.doi.org/10.1111/j.1863-2378.2008.01208.x.
13. Bondre VP, Jadi RS, Mishra AC, Yergolkar PN, Arankalle VA. 2007. West Nile virus isolates from India: evidence for a distinct genetic lineage. J. Gen. Virol. 88(Part 3):875-884. http://dx.doi.org/10.1099/vir.0.82403-0.
14. May FJ, Davis CT, Tesh RB, Barrett AD. 2011. Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J. Virol. 85:2964-2974. http://dx.doi.org/10.1128/JVI.01963-10.
15. Bakonyi T, Hubalek Z, Rudolf I, Nowotny N. 2005. Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg. Infect. Dis. 11:225-231. http://dx.doi.org/10.3201/eid1102.041028.
16. McMullen AR, Albayrak H, May FJ, Davis CT, Beasley DW, Barrett AD. 2013. Molecular evolution of lineage 2 West Nile virus. J. Gen. Virol. 94(Part 2):318-325. http://dx.doi.org/10.1099/vir.0.046888-0.
17. Daffis S, Lazear HM, Liu WJ, Audsley M, Engle M, Khromykh AA, Diamond MS. 2011. The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon response. J. Virol. 85:5664-5668. http://dx.doi.org/10.1128/JVI.00232-11.
18. Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, Diamond MS, Gale M, Jr. 2006. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J. Virol. 80:9424-9434. http://dx.doi.org/10.1128/JVI.00768-06.
19. Beasley DW, Whiteman MC, Zhang S, Huang CY, Schneider BS, Smith DR, Gromowski GD, Higgs S, Kinney RM, Barrett AD. 2005. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J. Virol. 79:8339-8347. http://dx.doi.org/10.1128/JVI.79.13.8339-8347.2005.
20. Laurent-Rolle M, Boer EF, Lubick KJ, Wolfinbarger JB, Carmody AB, Rockx B, Liu W, Ashour J, Shupert WL, Holbrook MR, Barrett AD, Mason PW, Bloom ME, Garcia-Sastre A, Khromykh AA, Best SM. 2010. The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J. Virol. 84:3503-3515. http://dx.doi.org/10.1128/JVI.01161-09.
21. Setoh YX, Prow NA, Hobson-Peters J, Lobigs M, Young PR, Khromykh AA, Hall RA. 2012. Identification of residues in West Nile virus premembraneprotein that influence viral particle secretion and virulence. J. Gen. Virol. 93(Part 9):1965-1975. http://dx.doi.org/10.1099/vir.0.044453-0.
22. Audsley M, Edmonds JH, Liu W, Mokhonov V, Mokhonova E, Melian EB, Prow N, Hall RA, Khromykh AA. 2011. Virulence determinants between New York 99 and Kunjin strains of West Nile virus. Virology 414:63-73. http://dx.doi.org/10.1016/j.virol.2011.03.008.
23. Schuessler A, Funk A, Lazear HM, Cooper DA, Torres S, Daffis S, Jha BK, Kumagai Y, Takeuchi O, Hertzog P, Silverman R, Akira S, Barton DJ, Diamond MS, Khromykh AA. 2012. West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferonmediated antiviral response. J. Virol. 86:5708-5718. http://dx.doi.org/10.1128/JVI.00207-12.
24. Beasley DW, Davis CT, Whiteman M, Granwehr B, Kinney RM, Barrett AD. 2004. Molecular determinants of virulence of West Nile virus in North America. Arch. Virol. Suppl. 18:35-41.
25. Hanna SL, Pierson TC, Sanchez MD, Ahmed AA, Murtadha MM, Doms RW. 2005. N-linked glycosylation of West Nile virus envelope proteins influences particle assembly and infectivity. J. Virol. 79:13262-13274. http://dx.doi.org/10.1128/JVI.79.21.13262-13274.2005.
26. Davis LE, DeBiasi R, Goade DE, Haaland KY, Harrington JA, Harnar JB, Pergam SA, King MK, DeMasters BK, Tyler KL. 2006. West Nile virus neuroinvasive disease. Ann. Neurol. 60:286-300. http://dx.doi.org/10.1002/ana.20959.
27. Sejvar JJ, Marfin AA. 2006. Manifestations of West Nile neuroinvasive disease. Rev. Med. Virol. 16:209-224. http://dx.doi.org/10.1002/rmv.501.
28. Colpitts TM, Conway MJ, Montgomery RR, Fikrig E. 2012. West Nile Virus: biology, transmission, and human infection. Clin. Microbiol. Rev. 25:635-648. http://dx.doi.org/10.1128/CMR.00045-12.
29. Samuel MA, Diamond MS. 2006. Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol. 80:9349-9360. http://dx.doi.org/10.1128/JVI.01122-06.
30. Getts DR, Matsumoto I, Muller M, Getts MT, Radford J, Shrestha B, Campbell IL, King NJ. 2007. Role of IFN-gamma in an experimental murine model of West Nile virus-induced seizures. J. Neurochem. 103: 1019-1030. http://dx.doi.org/10.1111/j.1471-4159.2007.04798.x.
31. Getts DR, Terry RL, Getts MT, Muller M, Rana S, Shrestha B, Radford J, Van Rooijen N, Campbell IL, King NJ. 2008. Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J. Exp. Med. 205:2319-2337. http://dx.doi.org/10.1084/jem.20080421.
32. Getts DR, Terry RL, Getts MT, Muller M, Rana S, Deffrasnes C, Ashhurst TM, Radford J, Hofer M, Thomas S, Campbell IL, King NJ. 2012. Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages. J. Neuroinflammation 9:246. http://dx.doi.org/10.1186/1742-2094-9-246.
33. Wang Y, Lobigs M, Lee E, Koskinen A, Mullbacher A. 2006. CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon. J. Gen. Virol. 87(Part 12):3599-3609. http://dx.doi.org/10.1099/vir.0.81306-0.
34. Stins MF, Badger JL, Kim KS. 2001. Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microb. Pathog. 30:19-28. http://dx.doi.org/10.1006/mpat.2000.0406.
35. Yamshchikov G, Borisevich V, Seregin A, Chaporgina E, Mishina M, Mishin V, Kwok CW, Yamshchikov V. 2004. An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for liveWNvaccine development. Virology 330: 304-312. http://dx.doi.org/10.1016/j.virol.2004.09.014.
36. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27:493-497.
37. Adams SC, Broom AK, Sammels LM, Hartnett AC, Howard MJ, Coelen RJ, Mackenzie JS, Hall RA. 1995. Glycosylation and antigenic variation among Kunjin virus isolates. Virology 206:49-56. http://dx.doi.org/10.1016/S0042-6822(95)80018-2.
38. Clark DC, Lobigs M, Lee E, Howard MJ, Clark K, Blitvich BJ, Hall RA. 2007. In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein. J. Gen. Virol. 88(Part 4):1175-1183. http://dx.doi.org/10.1099/vir.0.82609-0.
39. Hall RA, Broom AK, Hartnett AC, Howard MJ, Mackenzie JS. 1995. Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus-specific antibodies in sentinel animal serum. J. Virol. Methods 51:201-210. http://dx.doi.org/10.1016/0166-0934(94)00105-P.
40. Prince HE, Yeh C. 2013. Reactivity of human IgM binding murine monoclonal 6B6C1 (IgG2a) with other murine monoclonal IgG antibodies. J. Clin. Lab. Anal. 27:27-30. http://dx.doi.org/10.1002/jcla.21557.
41. Bielefeldt-Ohmann H, Tolnay AE, Reisenhauer CE, Hansen TR, Smirnova N, Van Campen H. 2008. Transplacental infection with noncytopathic bovine viral diarrhoea virus types 1b and 2: viral spread and molecular neuropathology. J. Comp. Pathol. 138:72-85. http://dx.doi.org/10.1016/j.jcpa.2007.10.006.
42. Tolnay AE, Baskin CR, Tumpey TM, Sabourin PJ, Sabourin CL, Long JP, Pyles JA, Albrecht RA, Garcia-Sastre A, Katze MG, Bielefeldt-Ohmann H. 2010. Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus. Arch. Virol. 155:905-914. http://dx.doi.org/10.1007/s00705-010-0662-8.
43. Diamond MS, Shrestha B, Mehlhop E, Sitati E, Engle M. 2003. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 16:259-278. http://dx.doi.org/10.1089/088282403322396082.
44. Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, Engle M. 2003. A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 198:1853-1862. http://dx.doi.org/10.1084/jem.20031223.
45. Butenko AM, Semashko IV, Skvortsova TM, Gromashevskii VL, Kondrashina NG. Detection of the Koutango virus (Flavivirus, Togaviridae) in Somalia. Med. Parazitol. 1986:65-68.
46. Karabatsos N. 1985. International catalogue of arboviruses, including certain other viruses of vertebrates, 3rd ed. American Society of Tropical Medicine and Hygiene for The Subcommittee on Information Exchange of the American Committee on Arthropod-borne Viruses, San Antonio, TX.
47. Coz J, Valade M, Cornet M, Robin Y. 1976. Transovarian transmission of a Flavivirus, the Koutango virus, in Aedes aegypti L. C. R. Acad. Sci. Hebd. Seances Acad. Sci. D 283:109-110.
48. Shope RE. 2003. Epidemiology of other arthropod-borne flaviviruses infecting humans. Adv. Virus Res. 61:373-391. http://dx.doi.org/10.1016/S0065-3527(03)61009-2.
49. Depoortere E, Kavle J, Keus K, Zeller H, Murri S, Legros D. 2004. Outbreak of West Nile virus causing severe neurological involvement in children, Nuba Mountains, Sudan, 2002. Trop. Med. Int. Health 9:730-736. http://dx.doi.org/10.1111/j.1365-3156.2004.01253.x.
50. Ching CY, Casals J, Bowen ET, Simpson DI, Platt GS, Way HJ, Smith CE. 1970. Arbovirus infections in Sarawak: the isolation of Kunjin virus from mosquitoes of the Culex pseudovishnui group. Ann. Trop. Med. Parasitol. 64:263-268.
51. Scherret JH, Poidinger M, Mackenzie JS, Broom AK, Deubel V, Lipkin WI, Briese T, Gould EA, Hall RA. 2001. The relationships between West Nile and Kunjin viruses. Emerg. Infect. Dis. 7:697-705. http://dx.doi.org/10.3201/eid0704.010418.
52. Scherret JH, Mackenzie JS, Hall RA, Deubel V, Gould EA. 2002. Phylogeny and molecular epidemiology of West Nile and Kunjin viruses. Curr. Top. Microbiol. Immunol. 267:373-390.
53. Shirato K, Miyoshi H, Goto A, Ako Y, Ueki T, Kariwa H, Takashima I. 2004. Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. J. Gen. Virol. 85(Part 12):3637-3645. http://dx.doi.org/10.1099/vir.0.80247-0.
54. Shrestha B, Diamond MS. 2004. Role of CD8+ T cells in control of West Nile virus infection. J. Virol. 78:8312-8321. http://dx.doi.org/10.1128/JVI.78.15.8312-8321.2004.
55. Samuel MA, Diamond MS. 2005. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 79:13350-13361. http://dx.doi.org/10.1128/JVI.79.21.13350-13361.2005.
56. Wang T, Scully E, Yin Z, Kim JH, Wang S, Yan J, Mamula M, Anderson JF, Craft J, Fikrig E. 2003. IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J. Immunol. 171:2524-2531. http://dx.doi.org/10.4049/jimmunol.171.5.2524.
57. Bourne N, Scholle F, Silva MC, Rossi SL, Dewsbury N, Judy B, De Aguiar JB, Leon MA, Estes DM, Fayzulin R, Mason PW. 2007. Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production. J. Virol. 81:9100-9108. http://dx.doi.org/10.1128/JVI.00316-07.
58. Cusick MF, Libbey JE, Patel DC, Doty DJ, Fujinami RS. 2013. Infiltrating macrophages are key to the development of seizures following virus infection. J. Virol. 87:1849-1860. http://dx.doi.org/10.1128/JVI.02747-12.
59. Medigeshi GR, Lancaster AM, Hirsch AJ, Briese T, Lipkin WI, Defilippis V, Fruh K, Mason PW, Nikolich-Zugich J, Nelson JA. 2007. West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J. Virol. 81:10849-10860. http://dx.doi.org/10.1128/JVI.01151-07.
60. Hail N, Jr, Carter BZ, Konopleva M, Andreeff M. 2006. Apoptosis effector mechanisms: a requiem performed in different keys. Apoptosis 11:889-904. http://dx.doi.org/10.1007/s10495-006-6712-8.
61. Kroemer G, Martin SJ. 2005. Caspase-independent cell death. Nat. Med. 11:725-730. http://dx.doi.org/10.1038/nm1263.
62. Brault AC, Huang CY, Langevin SA, Kinney RM, Bowen RA, Ramey WN, Panella NA, Holmes EC, Powers AM, Miller BR. 2007. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat. Genet. 39:1162-1166. http://dx.doi.org/10.1038/ng2097.
63. Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, Gorlatov S, Mehlhop E, Marri A, Chung KM, Ebel GD, Kramer LD, Fremont DH, Diamond MS. 2005. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 11:522-530. http://dx.doi.org/10.1038/nm1240.
64. Lee PD, Mukherjee S, Edeling MA, Dowd KA, Austin SK, Manhart CJ, Diamond MS, Fremont DH, Pierson TC. 2013. The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states. J. Virol. 87:13729-13740. http://dx.doi.org/10.1128/JVI.02340-13.
65. Balakrishnan A, Butte DK, Jadhav SM. 2013. Complete genome sequence of West Nile virus isolated from Alappuzha district, Kerala, India. Genome Announc. 1:e00230-13. http://dx.doi.org/10.1128/genomeA.00230-13.
66. Banerjee K. 1996. Emerging viral infections with special reference to India. Indian J. Med. Res. 103:177-200.
67. Shukla J, Saxena D, Rathinam S, Lalitha P, Joseph CR, Sharma S, Soni M, Rao PV, Parida M. 2012. Molecular detection and characterization of West Nile virus associated with multifocal retinitis in patients from southern India. Int. J. Infect. Dis. 16:e53-e59. http://dx.doi.org/10.1016/j.ijid.2011.09.020.